Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675922 · ClinicalTrials.gov registry record · Phase 2
Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 98
- Enrollment target
NCT00675922: Clinical Trial Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT00675922 is a Phase 2 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 98 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (26% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00675922, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 98 participants
- Enrollment target
Study Summary
Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).
Primary Outcome
Percent of infections following antimicrobial topical treatment with Sulfamylon vs Silver Nitrate Soaks.
Interventions
- DRUG Sulfamylon 5% and Silver Nitrate Soaks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 1995-07 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Why NCT00675922 stopped before completion
NCT00675922 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (26% lower).
The record links to 0 conditions, and to 1 intervention - of which Sulfamylon 5% and Silver Nitrate Soaks is the first listed.
NCT00675922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00675922 about?
NCT00675922 is a clinical study titled "Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks". Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).
What is the current status of trial NCT00675922?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 98 participants. The study started on 1995-07. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00675922?
The interventions under investigation include: Sulfamylon 5% and Silver Nitrate Soaks (DRUG).
Who is sponsoring clinical trial NCT00675922?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00675922's enrollment target sits among peer trials
98 743rd of 2000 higher than 1,255 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia